Quick Takeaways
- Maricel Apuli has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $9,202,735.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Maricel Apuli
- Location
- Palo Alto, CA
- Summary
- The estimated net worth of Maricel Apuli is at least $9,202,735 dollars as of 20 Mar 2026. Maricel Apuli is the Chief Accounting Officer of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $9.2M.
- Signature
- /s/ Maricel Apuli
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Maricel Apuli and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: BridgeBio Pharma, Inc. ($9,202,735).
- Past-year value change for that position: -$403,367.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Maricel Apuli
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | Chief Accounting Officer | $9,202,735 | -$403,367 | -4.2% | 18 Mar 2026 |
Insider Transactions Reported by Maricel Apuli:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.